Eastman Chemical to Acquire Genovique Specialties

Eastman Chemical said on Wednesday it will acquire Genovique Specialties in a deal that will increase its footprint in the growing market for specialty plasticizers. Financial details of the transaction were not disclosed, but Eastman said it expected the deal to boost its full-year 2010 earnings.

The transaction was also announced by Arsenal Capital Partners, a New York-based private equity firm which owns Genovique Specialties.

Eastman said the acquisition will establish the company as a global leader in non-phthalate plasticizers. Plasticizers or dispersants are additives that increase the plasticity or fluidity of a material such as plastics, cement and concrete.

Genovique Specialties, including its manufacturing operations in Chestertown, Md., Estonia, and a joint venture in Wuhan, China, will become part of Eastman's Performance Chemicals and Intermediates segment.

 

Company

Eastman Chemical Company

200 South Wilcox Drive
37662 Kingsport

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.